Liya Wu1, Katja Piotrowski1, Tiina Rau1, Elisa Waldmann1, Uli C Broedl1, Hans Demmelmair2, Berthold Koletzko2, Renee G Stark3, Jutta M Nagel1, Christos S Mantzoros4, Klaus G Parhofer5. 1. Division of Endocrinology and Metabolism at Medical Department 2, University of Munich Medical Center, Munich, Germany. 2. Division of Metabolic and Nutritional Medicine at Dr. von Hauner Children's Hospital, University of Munich Medical Center, Munich, Germany. 3. Helmholtz Zentrum Muenchen, Institute for Health Economics and Healthcare Management, Neuherberg, Germany. 4. Division of Endocrinology, Diabetes, and Metabolism at Beth Israel Deaconess Medical Center, Boston, MA, USA. 5. Division of Endocrinology and Metabolism at Medical Department 2, University of Munich Medical Center, Munich, Germany. Electronic address: klaus.parhofer@med.uni-muenchen.de.
Abstract
BACKGROUND: Walnut consumption is associated with reduced risk of coronary heart disease (CHD). OBJECTIVE: We assessed the effect of walnuts on lipid and glucose metabolism, adipokines, inflammation and endothelial function in healthy Caucasian men and postmenopausal women ≥50years old. DESIGN:Forty subjects (mean±SEM: age 60±1years, BMI 24.9±0.6kg/m(2); 30 females) were included in a controlled, cross-over study and randomized to receive first a walnut-enriched (43g/d) and then a Western-type (control) diet or vice-versa, with each lasting 8weeks and separated by a 2-week wash-out. At the beginning and end of each diet phase, measurements of fasting values, a mixed meal test and an assessment of postprandial endothelial function (determination of microcirculation by peripheral artery tonometry) were conducted. Area under the curve (AUC), incremental AUC (iAUC) and treatment×time interaction (shape of the curve) were evaluated for postprandial triglycerides, VLDL-triglycerides, chylomicron-triglycerides, glucose and insulin. RESULTS: Compared with the control diet, the walnut diet significantly reduced non-HDL-cholesterol (walnut vs. control: -10±3 vs. -3±2mg/dL; p=0.025) and apolipoprotein-B (-5.0±1.3 vs. -0.2±1.1mg/dL; p=0.009) after adjusting for age, gender, BMI and diet sequence. Total cholesterol showed a trend toward reduction (p=0.073). Fasting VLDL-cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides and glucose, insulin, HOMA-IR, and HbA1c did not change significantly. Similarly, fasting adipokines, C-reactive protein, biomarkers of endothelial dysfunction, postprandial lipid and glucose metabolism and endothelial function were unaffected. CONCLUSION: Daily consumption of 43g of walnuts for 8weeks significantly reduced non-HDL-cholesterol and apolipoprotein-B, which may explain in part the epidemiological observation that regular walnut consumption decreases CHD risk.
RCT Entities:
BACKGROUND: Walnut consumption is associated with reduced risk of coronary heart disease (CHD). OBJECTIVE: We assessed the effect of walnuts on lipid and glucose metabolism, adipokines, inflammation and endothelial function in healthy Caucasian men and postmenopausal women ≥50years old. DESIGN: Forty subjects (mean±SEM: age 60±1years, BMI 24.9±0.6kg/m(2); 30 females) were included in a controlled, cross-over study and randomized to receive first a walnut-enriched (43g/d) and then a Western-type (control) diet or vice-versa, with each lasting 8weeks and separated by a 2-week wash-out. At the beginning and end of each diet phase, measurements of fasting values, a mixed meal test and an assessment of postprandial endothelial function (determination of microcirculation by peripheral artery tonometry) were conducted. Area under the curve (AUC), incremental AUC (iAUC) and treatment×time interaction (shape of the curve) were evaluated for postprandial triglycerides, VLDL-triglycerides, chylomicron-triglycerides, glucose and insulin. RESULTS: Compared with the control diet, the walnut diet significantly reduced non-HDL-cholesterol (walnut vs. control: -10±3 vs. -3±2mg/dL; p=0.025) and apolipoprotein-B (-5.0±1.3 vs. -0.2±1.1mg/dL; p=0.009) after adjusting for age, gender, BMI and diet sequence. Total cholesterol showed a trend toward reduction (p=0.073). Fasting VLDL-cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides and glucose, insulin, HOMA-IR, and HbA1c did not change significantly. Similarly, fasting adipokines, C-reactive protein, biomarkers of endothelial dysfunction, postprandial lipid and glucose metabolism and endothelial function were unaffected. CONCLUSION: Daily consumption of 43g of walnuts for 8weeks significantly reduced non-HDL-cholesterol and apolipoprotein-B, which may explain in part the epidemiological observation that regular walnut consumption decreases CHD risk.
Authors: Katherine A Sauder; Cindy E McCrea; Jan S Ulbrecht; Penny M Kris-Etherton; Sheila G West Journal: Metabolism Date: 2015-07-30 Impact factor: 8.694
Authors: Danielle Cahoon; Shruti P Shertukde; Esther E Avendano; Jirayu Tanprasertsuk; Tammy M Scott; Elizabeth J Johnson; Mei Chung; Nanguneri Nirmala Journal: Ann Med Date: 2021-12 Impact factor: 4.709
Authors: Sonia Blanco Mejia; Cyril W C Kendall; Effie Viguiliouk; Livia S Augustin; Vanessa Ha; Adrian I Cozma; Arash Mirrahimi; Adriana Maroleanu; Laura Chiavaroli; Lawrence A Leiter; Russell J de Souza; David J A Jenkins; John L Sievenpiper Journal: BMJ Open Date: 2014-07-29 Impact factor: 2.692